We are live on
!
Find out more
CA
Cortland Associates Portfolio holdings
AUM
$692M
1-Year Est. Return
5%
This Fund
S&P 500
This Quarter
Est. Return
+9.68%
1 Year Est. Return
-5%
3 Year Est. Return
+57.07%
5 Year Est. Return
+61.48%
10 Year Est. Return
+413.35%
AUM
$516M
AUM Growth
+$84.7M
(+20%)
Cap. Flow
+$46.8M
Cap. Flow
% of AUM
9.07%
Top 10 Holdings %
Top 10 Hldgs %
72.32%
Holding
48
New
4
Increased
15
Reduced
12
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$15.2M |
| 2 |
Perrigo
PRGO
|
+$15.2M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$6.61M |
| 4 |
CVS Health
CVS
|
+$6.08M |
| 5 |
Cognizant
CTSH
|
+$1.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$442K |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$299K |
| 3 |
Blue Bird Corp
BLBD
|
+$243K |
| 4 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
+$183K |
| 5 |
Visa
V
|
+$81.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.55% |
| 2 | Financials | 24.39% |
| 3 | Technology | 12.85% |
| 4 | Communication Services | 11.51% |
| 5 | Consumer Discretionary | 7.45% |
Similar funds
CL
CPA
NMC
SSA
WC
CGIC
LCP
SAM
Cortland Associates's Q4 2015 Portfolio in Review
As of Q4 2015, Cortland Associates held 48 positions worth $516M, up 20% from $431M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Cortland Associates deployed $46.8M of net new capital in Q4 2015, opening 4 new positions and adding to 15 existing holdings. Its largest new stake was Centene: 512,304 shares worth $16.9M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 31% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Monsanto Co, an estimated $442K trimmed.
- Cortland Associates's largest Q4 2015 buy was Centene: 512,304 shares worth $16.9M.
- Cortland Associates added most to Express Scripts Holding Company in Q4 2015, an estimated $6.61M increase.
- Cortland Associates's biggest Q4 2015 reduction was Monsanto Co, cutting an estimated $442K.
- Cortland Associates fully exited Endocyte, Inc. Common Stock in Q4 2015, selling an estimated $183K.
- Cortland Associates's ten largest holdings make up 72% of its $516M portfolio in Q4 2015.
- Cortland Associates opened 4 new positions and closed 4 in Q4 2015.
- Cortland Associates's portfolio value rose 20% quarter-over-quarter to $516M.
Based on Cortland Associates's 13F filing for Q4 2015, filed 19 Jan 2016.